E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/13/2020 in the Prospect News Investment Grade Daily.

Fitch ups, withdraws Allergan

Fitch Ratings said it upgraded and withdrew the ratings of Allergan plc, Allergan, Inc. and Forest Laboratories, LLC to BBB from BBB-.

The upgrade is supported by AbbVie Inc.’s acquisition of Allergan, the assumption of Allergan’s debt by AbbVie, and the expectation the combined company will operate with a credit profile at least commensurate with a BBB rating within 24 months of the acquisition, Fitch said.

The outlook is positive.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.